Antibody Drug Conjugate Ado-trastuzumab Emtansine (IMAGE)

University of California - San Diego

Antibody Drug Conjugate Ado-trastuzumab Emtansine

Caption

UC San Diego School of Medicine and Moores Cancer Center researchers report that in mouse models tumors testing positive for a protein called human epidermal growth factor receptor 2 (HER2) were sensitized to a combination of radiation therapy and an antibody drug conjugate (ADC), called ado-trastuzumab emtansine (T-DM1) pictured here in red binding to tumor cells.

Credit

UC San Diego Health

Usage Restrictions

Use photo credit as indicated

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.